Soluble factors from biofilms of wound pathogens modulate human bone marrow-derived stromal cell differentiation, migration, angiogenesis, and cytokine secretion
- Catherine L Ward†1Email author,
- Carlos J Sanchez Jr†1,
- Beth E Pollot1,
- Desiree R Romano1,
- Sharanda K Hardy1,
- Sandra C Becerra1,
- Christopher R Rathbone1 and
- Joseph C Wenke1
© Ward et al.; licensee BioMed Central. 2015
Received: 22 September 2014
Accepted: 12 March 2015
Published: 28 March 2015
Chronic, non-healing wounds are often characterized by the persistence of bacteria within biofilms - aggregations of cells encased within a self-produced polysaccharide matrix. Biofilm bacteria exhibit unique characteristics from planktonic, or culture-grown, bacterial phenotype, including diminished responses to antimicrobial therapy and persistence against host immune responses. Mesenchymal stromal cells (MSCs) are host cells characterized by their multifunctional ability to undergo differentiation into multiple cell types and modulation of host-immune responses by secreting factors that promote wound healing. While these characteristics make MSCs an attractive therapeutic for wounds, these pro-healing activities may be differentially influenced in the context of an infection (i.e., biofilm related infections) within chronic wounds. Herein, we evaluated the effect of soluble factors derived from biofilms of clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa on the viability, differentiation, and paracrine activity of human MSCs to evaluate the influence of biofilms on MSC activity in vitro.
Exposure of MSCs to biofilm-conditioned medias of S. aureus and P. aeruginosa resulted in reductions in cell viability, in part due to activation of apoptosis. Similarly, exposure to soluble factors from biofilms was also observed to diminish the migration ability of cells and to hinder multi-lineage differentiation of MSCs. In contrast to these findings, exposure of MSCs to soluble factors from biofilms resulted in significant increases in the release of paracrine factors involved in inflammation and wound healing.
Collectively, these findings demonstrate that factors produced by biofilms can negatively impact the intrinsic properties of MSCs, in particular limiting the migratory and differentiation capacity of MSCs. Consequently, these studies suggest use/application of stem-cell therapies in the context of infection may have a limited therapeutic effect.
KeywordsStaphylococcus aureus Pseudomonas aeruginosa Biofilm Mesenchymal stromal cells Wound healing Differentiation Angiogenesis
Effective wound healing is a highly coordinated, multistage process involving multiple host mechanisms, including inflammation, neovascularization, cell proliferation, extracellular matrix formation, and cellular maturation and remodeling. In contrast to acute wounds, which often heal with only minimal medical treatment, chronic wounds are primarily characterized by dysregulated inflammatory responses and cell defense mechanisms, which often result in delayed and/or non-healing of the wound . The presence of microorganisms within tissues is a major risk factor for the development of chronic wounds. Recent studies evaluating the biodiversity within various types of chronic wounds demonstrated the presence of multiple species of bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, Bacteroides spp., Peptostreptococcus, Enterococcus spp [2,3]. In contrast to surviving in a predominately planktonic form, such as in vitro cultures, bacteria adapt to and persist within chronic wounds as a heterogeneous population that is predominately attached to host tissues, known as a biofilm [4,5]. To date numerous studies have demonstrated the presence of bacterial biofilms in various settings involving chronic human infections, indicating a causal relationship between the presence of bacterial biofilms and the development of these types of infection. For example, in a sample of patients with chronic, non-healing cutaneous wounds, over half were characterized as containing biofilm . Similarly, recent reports evaluating nonunion of long bone fractures have also shown that the presence of biofilms was frequently associated with non-osseous union . Although the precise mechanisms through which biofilm bacteria contribute to and promote wound chronicity is not completely understood, a few studies have demonstrated that soluble factors released from the biofilm can negatively impact cell function [4,5,7]. Studies evaluating interactions between biofilm communities and cells involved in wound healing will be central to further our understanding of how these processes may be perturbed during infection.
Regenerative cells known as mesenchymal stem cells, multipotent mesenchymal stromal cells, and marrow stromal cells (hereafter referred to as “MSCs” ) contribute to wound healing directly through differentiation [9,10], and indirectly through the release of paracrine factors, such as stromal derived factor 1 (SDF-1) [11,12] and vascular endothelial growth factor (VEGF) . Additionally, MSCs have also been shown to have antimicrobial properties through activities mediated by the release of the antimicrobial peptide LL-37 [14-16]. The combined properties of MSCs make them a critical element of intrinsic wound healing, and a highly attractive candidate for cell based therapies for tissue repair and regeneration. To date, numerous studies have evaluated the potential therapeutic applications of MSCs for tissue regeneration. However, the vast majority of these studies have primarily utilized wound models that lack an infectious component. This is a particularly important lapse, as the functional activity of MSCs may be altered in the presence of inflammatory mediators produced by the host as well as bacterial components that may accumulate within a chronic wound. In support of this, recent studies have demonstrated differential effects to normal healing and differentiation of MSCs in the presence of purified microbial cell wall components (e.g., Gram-negative lipopolysaccharide (LPS) and Gram-positive lipoteichoic acid, (LTA)) [17,18], inflammatory cytokines , peripheral blood mononucleated cells (PBMCs) , and heat-inactivated bacteria . Consequently, these studies indicate that the ability of MSCs to promote healing can be negatively affected in the context of the wound environment.
Given the importance of bacterial biofilms in the development of chronic wounds, the ability of these communities to inhibit wound healing, and the likely interactions with host cells such as MSCs, herein we evaluated the effect of soluble factors from biofilms of clinical isolates of S. aureus and P. aeruginosa on the viability, differentiation, and paracrine activity of human bone marrow stromal cells (hBMSCs) in vitro.
hBMSCs and cell culture
Primary human bone marrow stromal cells (hBMSCs, STEMCELL Technologies, Vancouver, Canada) were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco®, Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) and 10 U penicillin mL−1 and streptomycin 10 μg mL−1 at 37°C in 5 % CO2. For all studies described herein, hBMSCs between passages 1–4 were used.
Bacterial strains and growth conditions
UAMS-1 (ATCC strain 49230) is a methicillin-susceptible S. aureus clinical strain of the USA 200 clonal group and a well characterized osteomyelitis isolate . P. aeruginosa, strain SAMMC-418, is a multidrug-resistant, pulsed-field type 2, clinical wound isolate selected from a strain collection at the San Antonio Military Medical Center (SAMMC, Ft. Sam Houston, TX) . Both strains used in this study have been previously characterized for biofilm formation. Bacteria were cultured in Cation-Adjusted Mueller Hinton Broth (MHB-II) or on blood agar plates at 37°C.
Biofilm formation and preparation of biofilm-conditioned media (BCM)
Biofilm formation and generation of conditioned media were performed as previously described [24,25]. Briefly, 500 μL of a 1:100 dilution of overnight bacterial cultures (~106 CFU/mL) were added to transwell tissue culture inserts (0.4 μm pore size, Corning Inc, Corning, NY) and grown under static conditions for 48 hr at 37°C. Culture inserts were washed, placed into DMEM, and maintained at 37°C for up to 4 days. BCM was collected daily and replaced with fresh media. Consistent with previous studies and to reduce variations between individual collections of BCM, individual fractions were pooled [24,25]. Pooled BCMs were filter-sterilized using a 0.2 μm syringe filter (Fisher, Pittsburgh, PA) to remove any bacteria, pH adjusted to 7.4, and stored at −80°C. Sterility of collected BCM was assessed by spot plating 10 μL aliquots of BCM onto MHB-II plates and incubating the plates overnight at 37°C.
Enumeration of bacteria and protein within biofilms
To evaluate the relationship between bacteria within biofilms and level of protein present within the conditioned medias over time, biofilms of S. aureus UAMS-1 and P. aeruginosa SAMMC-418 were grown in transwells as described above and viable bacteria along with total protein within the collected medias were measured daily for up to five days. Bacteria were enumerated by removing the polycarbonate membrane of the transwell, followed by sonication of the entire membrane in 1 mL of PBS and enumeration by plating serial dilutions on blood agar plates. Protein corresponding to the same time point and within the media was quantified using a bicinchonic acid (BCA) assay (Pierce, Rockford, IL) following the manufacturer’s protocol.
Preparation of planktonic-conditioned media (PCM)
Planktonic bacterial cultures of S. aureus and P. aeruginosa were grown under conditions to produce similar cell densities of the biofilm cultures. Briefly, individual bacterial colonies from overnight plate cultures were inoculated into MHB-II and grown to early stationary phase (~109 CFU/mL). Following growth in liquid culture, bacteria were harvested by centrifugation and resuspended in sterile DMEM, then incubated at 37°C with agitation for an additional 24 hr. Following overnight incubation, planktonic bacteria were then harvested by centrifugation and the supernatants were collected, filter sterilized and adjusted to pH 7.4 prior to use in experimental assays. Similar to the BCM, the PCM was spot plated onto MHB-II plates and incubated overnight at 37°C to ensure sterility of supernatants.
Cells were seeded into 48-well plates (at 5 × 103 cells/cm2), grown to ~50% confluence, and exposed to either purified bacterial cell wall components, including lipoteichoic acid (LTA) from Staphylococcus aureus or lipopolysaccharide (LPS) from Eschrichia coli 0111:B4 (Sigma Aldrich, St. Louis, MO) at 10 μg/mL , PCM or BCM of S. aureus and P. aeruginosa for up to 7 days in vitro. As a control for the treatment groups, cell media supplemented with PBS at similar concentrations were used for comparison (vehicle control). Viability was assessed for up to 7 days post-exposure using a LIVE/DEAD© assay kit (Life Technologies™, Grand Island, NY) by measuring fluorescence at EX485nm/EM530nm using a microplate reader (SPECTRAmax M2, Molecular Devices, Sunnyvale, CA) per the manufacturer’s instructions. Cell viability was expressed as a ratio of an untreated, media only, growth control for each respective timepoint.
Measurement of Caspase-3/7 activity
Caspase-3/7 activity in hBMSCs following exposure to BCM was determined using the SensoLyte™ Homogenous AFC Caspase-3/7 Assay Kit (AnaSpec, San Jose, CA) for up to 7 days, as previously described . Briefly, 25 μL of cell media from BCM-exposed hBMSCs was combined with the caspase-3/7 substrate solution to initiate an enzymatic reaction to cleave and generate a fluorophore. Fluorescence was detected at EX380nm/EM500nm using a microplate reader. Caspase activity, measured by released caspase-3/7 found in the media, was expressed as a ratio of an untreated growth control. As in viability experiments, caspase activity was also evaluated in cells exposed to vehicle control, purified cell wall components, and PCM of both S. aureus and P. aeruginosa.
Western blot analysis
Protein analysis was performed on cell lysates of hBMSCs exposed to BCM after 7 days in culture. Briefly, whole cell lysates were prepared by lysing cells with CelLytic™ M (Sigma-Aldrich, St. Louis, MO) followed by treatment with protease inhibitor cocktail (Sigma-Aldrich). Triplicate samples were pooled and concentrated using 3000 NMWL centrifugal devices (Millipore, Billerica, MA). Total cellular protein was determined by bicinchoninic acid (BCA) assay (Pierce). Whole cells lysates (20 μg) were separated on a 3-8% Tris-Acetate gel (NuPAGE®, Life Technologies, Grand Island, NY) and electrophoretically transferred to nitrocellulose membranes. Membranes were blocked with PBS containing 5% bovine serum albumin (BSA) and 0.1% Tween-20 for 1 hr and incubated overnight at 4°C with primary antibodies including; rabbit anti-human caspase-3, rabbit anti-human adiponectin, rabbit anti-human PPARγ, rabbit anti-human RUNX2, (1:1000; Cell Signaling Technology®, Danvers, MA), goat anti-human leptin, rat anti-human alkaline phosphatase (ALP) (0.1 μg/mL, R&D Systems, Minneapolis, MN), rabbit anti-human osteocalcin (OCN) (1:1000; abcam®, Cambridge, MA) and mouse anti-human Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody (1:500; Millipore, Billerica, MA). Following incubation, membranes were washed then incubated with the appropriate HRP-conjugated secondary antibody (1:3000–1:5000) for 1 hr at room temperature for detection of the proteins by chemiluminesence. Relative protein levels were determined by comparative densitometric analysis of western blot bands using the Odyssey Fc system (LI-COR Biosciences, Lincoln, NE). For each protein examined, the membrane initially probed was stripped, and the amount of actin was determined using antibodies against GAPDH. Relative levels of protein were determined by dividing the intensity of the tested protein band to that of GAPDH within the same lane and membrane.
Cells were cultured at 5 × 103 cells/cm2 in 24-well plates and grown to ~80% confluence. For adipogenic differentiation, cells were cultured in growth media supplemented with isobutyl-methyl xanthine (50 mM), indomethacin (200 μM), insulin (1 μM), and dexamethasone (0.1 μM) (Sigma-Aldrich, St. Louis, MO). Differentiation control groups contained an equivalent volume of unsupplemented DMEM (as a vehicle control) as BCM in the experimental groups. Cells were cultured for up to 21 days, with fresh media changes every 3–4 days. At days 7, 14 and 21, cells were fixed in 10% formalin, stained for 10–15 min at room temperature with a working solution of Oil Red O stain (0.0035 g/mL in isopropanol, diluted 6:4 in deionized water), rinsed 3x with distilled water, and oil droplets were visualized by light microscopy at 40x magnification (Olympus IX71 microscope, Center Valley, PA). For quantification of staining, Oil Red was extracted from cells using 100% isopropanol and absorbance at 500 nm was measured. Results were expressed as a ratio of an undifferentiated growth control. Protein expression levels of genes involved adipogenic differentiation, including adiponectin, PPARγ, and leptin, was also performed on hBMSCs after 7 days of differentiation by western blot analysis as described above.
For osteogenic differentiation, cells were cultured as above in growth media supplemented with ascorbate-2 phosphate (50 μM), β-glycerolphosphate (10 mM), and dexamethasone (0.1 μM) (Sigma-Aldrich, St. Louis, MO). At days 7, 14 and 21, cells were fixed with 10% formalin, stained with 2% w/v Alizarin Red S in deionized water (pH 7.0) for 20 min, washed with PBS, and calcium deposits were visualized by light microscopy at 40x magnification (Olympus IX71 microscope, Center Valley, PA). For quantification of staining, Alizarin Red was extracted from cells using 0.5 N HCl in 5% SDS solution and absorbance at 415 nm was measured. Results were expressed as a ratio of an undifferentiated growth control. Protein expression levels of genes involved osteogenic differentiation, including RUNX2, OCN, and ALP, was also performed on hBMSCs after 7 days of differentiation by western blot analysis as described above.
RNA extraction and quantitative real-time PCR (qRT-PCR)
RNA extraction and isolation from hBMSCs exposed to BCM was performed as previously described . First strand synthesis of cDNA was achieved with SuperScript III first-strand synthesis supermix with oligo-dT primers (InvitrogenTM, Grand Island, NY) for each RNA sample using a PTC-100 Thermal Cycler (GMI Inc, Ramsey, MN). For genes of interest, quantitative real-time polymerase chain reaction (qRT-PCR) was performed using a Bio-Rad C1000 system and analyzed using iQ5 software (BioRad, Hercules, CA) using 10 ng of RNA per reaction. Primers utilized in this study for genes of interest, including peroxisome proliferator-activated receptor gamma (PPARγ), adiponectin, leptin, alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2), and bone gamma-carboxyglutamic acid-containing protein (osteocalcin, OCN), were purchased from SABiosciences (Valencia, CA) and the amplification reactions were performed using SYBR Green Super Mix (BioRad, Hercules, CA) following the optimized conditions recommended by the manufacturer. Three independent biological experiments with three technical replicates were performed for each reaction. Transcript levels were normalized to GAPDH mRNA. Relative expression levels were calculated using the 2–ΔCt method . Relative fold differences in gene expression were calculated as a ratio of the normalized values compared to relative gene expression in undifferentiated controls.
Capillary tube formation assay
Angiogenesis, as determined by capillary tube formation of hBMSCs, was assessed using a matrigel-based assay as previously described . Briefly, individual wells of a 48-well tissue culture plate were coated with 100 μL of Matrigel (100 mg/mL, BD Biosciences, San Jose, CA) and allowed to polymerize for 1 hr at 37°C. Cells were seeded on top of the gels at 2 x 104 cells/well in 200 μL of media containing BCM. At 2, 6, and 16 hours post-exposure, six images per well were taken at 40× and 100× magnification with an inverted microscope (Olympus IX71 microscope, Center Valley, PA) to analyze the development of capillary-like networks using phase contrast microscopy. Image analysis was performed using Image J V1.44p software (U. S. National Institutes of Health, Bethesda, MD). Capillary tube formation was assessed at each time point by counting the number of capillary-like tubules and by measuring tube length (μm) between connectors.
Functional migration analysis of hBMSCs was performed using an Oris™ Cell Migration Assay-FLEX (Platypus Technologies, Madison, WI) according to the manufacturer’s instructions. Briefly, cells were seeded into black 96-well clear bottom microplates (5 × 103cells/cm2) containing a rubber stopper at the plate center, creating a void circle (2 mm diameter) area. hBMSCs were grown to ~80% confluence at which time the stoppers and media were removed, and replenished with media containing BCM. Positive control wells containing growth media (0% BCM, with an equivalent volume of unsupplemented DMEM as the BCM experimental groups to represent a vehicle control) and negative control wells with stopper in place (depicting no migration) were maintained in the well plate. Cells were allowed to migrate for 3 days. Media was then removed and cells were stained with Vybrant® CFDA SE Cell Tracer dye (InvitrogenTM, Grand Island, NY). Wells were viewed at 40x magnification using an inverted microscope (Olympus IX71 microscope, Center Valley, PA) with a FITC filter to image the entire area of migration. Using Adobe® Photoshop® CS3 (San Jose, CA), images were converted to black and white, and threshold was recorded. Quantification was performed by calculating a ratio based on the threshold of the experimental well images to that of a full growth control (i.e., 100% confluency). This ratio was deemed as the amount of migration that occurred into the void area over the course of 3 days.
Quantification of cytokines
Enzyme-linked immunosorbant assays (ELISAs) were performed to quantify cytokines in culture supernatants (media) from hBMSCs exposed to BCM for 1 and 3 days. ELISA kits for Tumor necrosis factor α (TNF-α) (R&D Systems, Minneapolis, MN), Interleukin-6 (IL-6) (R&D Systems, Minneapolis, MN), stromal cell derived factor 1a (SDF-1) (TSZ ELISATM, Framingham, MA), vascular endothelial growth factor (VEGF) (Quantikine®, Minneapolis, MN), and human cathelicidin LL-37 (Hycult® Biotech, Netherlands) were performed according to the manufacturer’s instructions. Briefly, supernatants (media) were collected from individual wells containing hBMSCs exposed to BCM at days 1 and 3 (0.5 mL volumes), treated with protease inhibitor cocktail (Sigma-Aldrich, St. Louis MO), and stored at −80°C until analysis. Total protein in samples was quantified using a BCA assay (Pierce). Cytokine levels in supernatants were quantified by extrapolation from standard curves generated using recombinant protein for each respective cytokine, and determined concentrations were normalized to total protein content in each supernatant sample as determined by the BCA assay.
Statistical analysis was performed using one-way ANOVA with a Tukey’s multiple comparison post hoc test for comparisons between groups. P values of <0.05 were considered to be statistically significant. All assays were performed in triplicate.
Soluble factors from biofilms reduce the viability of hBMSCs, in part due to the activation of apoptosis
Multilineage differentiation potential of hBMSCs is decreased in the presence of soluble factors from biofilms
Relative expression of genes involved in adipogenic differentiation
0.70 ± 0.37
0.11 ± 0.71
S. aureus UAMS-1
0.29 ± 0.26
0.19 ± 0.50
P. aeruginosa SAMMC-418
0.50 ± 0.29
0.20 ± 0.74
0.00 ± 1.42
0.24 ± 1.12
S. aureus UAMS-1
0.10 ± 1.35
0.01 ± 1.03
P. aeruginosa SAMMC-418
0.00 ± 1.36
0.00 ± 1.60
0.06 ± 1.02
0.90 ± 0.88
S. aureus UAMS-1
0.01 ± 1.01
0.03 ± 0.60
P. aeruginosa SAMMC-418
0.01 ± 1.00
0.00 ± 0.61
Relative expression of genes involved in osteogenic differentiation
13.11 ± 0.34
7.69 ± 0.51
S. aureus UAMS-1
3.23 ± 0.25
0.27 ± 0.38
P. aeruginosa SAMMC-418
0.53 ± 0.35
0.07 ± 0.45
0.53 ± 0.82
0.91 ± 0.72
S. aureus UAMS-1
0.21 ± 0.99
1.24 ± 0.70
P. aeruginosa SAMMC-418
0.13 ± 0.62
1.35 ± 0.67
0.34 ± 0.36
31.91 ± 0.53
S. aureus UAMS-1
0.01 ± 0.35
0.01 ± 0.86
P. aeruginosa SAMMC-418
0.02 ± 0.27
0.00 ± 0.52
Migration of hBMSCs is hindered by the presence of biofilm-derived factors
The ability of cells to migrate towards sites of injury is central to enacting their roles during the wound healing process. Using a void circle migration assay, the effect of BCM on the migratory capacity of hBMSCs was assessed. After 3 days, in the absence of BCM, cells were able to almost completely fill the void space in the standard migration assay (i.e. >80% confluence). In contrast, in the presence of BCM from S. aureus and P. aeruginosa, the migration of hBMSCs was significantly impaired (Figure 4D), with few to little cells migrating into the void space (i.e. <10%). Quantification of the ratio of migration, as determined by measuring the cell amount within the void area, demonstrated that on average, the exposure to BCM reduced the migration capacity by > 6 fold compared to the untreated growth control (Figure 4E).
hBMSCs enhance the production of inflammatory and wound healing cytokines in response to soluble factors from biofilms
In response to injury, the recruitment of host MSCs and their subsequent activity within wounds is a central part in the healing process. MSCs participate in wound healing directly, through differentiation and replacement of damaged tissues, and indirectly through paracrine activities, which can orchestrate a regenerative microenvironment [30-34], and modulate host immune responses [9,10,35]. However, within infected wounds, the persistence of microbial pathogens, in addition to the damaging environment caused by pathogen exposure, could differentially affect the properties of MSCs. Indeed, recent studies have demonstrated that the differentiation capacity of MSCs can be modulated in an inflammatory environment  as well as in the presence of purified cell wall components of bacterial pathogens [18,20,21]. Although these studies have provided insight into the interactions between MSCs and signals that would be present in an infected wound environment, evaluation of the effect of soluble factors of biofilms, the predominate mode of growth within tissues, on MSCs has not been previously reported.
Bacterial biofilms have been shown to directly disrupt the normal wound healing process in vitro and in vivo [37-40]. This is, in part, thought to be mediated through the activity of soluble bacterial products released from the biofilm on host cells. Recent studies comparing the effects of biofilm to planktonic cultures have shown that biofilms can induce distinctive inflammatory responses and differentially activate apoptosis in human cell lines [25,41]. Similarly, exposure of osteoblasts to soluble biofilm products resulted in increased apoptosis, decreased osteogenesis and enhanced release of factors promoting bone resorption . Prior to the current study, the effect of biofilms on hBMSCs had not been studied. The present study showed early and pronounced negative effects on hBMSC viability along with increases in caspase activity following exposure to soluble factors from biofilms of S. aureus and P. aeruginosa. Comparisons of planktonic versus biofilm conditioned medias have demonstrated that there is a substantial overlap between the extracellular proteomes, with only a small minority of proteins unique to either phenotype [24,25,42]. Because biofilms are heterogeneous in their composition, having bacteria in the planktonic and biofilm state, the observed effects on hBMSCs are likely due to the cumulative effect of released proteins within conditioned medias expressed by both phenotypes, such as exoenzymes and exotoxins . Future studies evaluating the soluble factors released by biofilms of these different bacterial species may provide further insight into the identity of these soluble factors as well as providing potential mechanisms for the loss of cell viability. Interestingly, exposure of hBMSCs to BCM of P. aeruginosa was observed to be much more toxic to cells compared to the conditioned media of S. aureus. Evaluation of viable bacteria within and released protein during biofilm growth revealed only moderate differences between the two strains, indicating that the observed differences on cell viability may not have been the result of higher protein concentrations or bacterial numbers within the biofilm, but due to differences in the factors expressed by the two bacterial species.
In addition to decreased cell viability, successful direct functional differentiation processes of MSCs were also significantly decreased in the presence of BCM. Specifically, the processes of adipogenesis (defined by transcriptional factors PPARγ, adiponectin, and leptin, which are either regulators of adipocyte differentiation or secreted by mature adipocytes) and osteogenesis (defined by transcriptional factors RUNX2, ALP and OCN, which are essential for osteoblast differentiation, matrix elaboration, and bone mineralization and calcium ion homeostasis, respectively) were severely disrupted by the factors associated with both Gram-negative and Gram-positive bacterial biofilms. Further, functional assays supported this finding, showing little to no oil droplet formation or calcium deposition for cells undergoing adipogenesis and osteogenesis in the presence of BCM, respectively. Conversely, a previous study demonstrated that exposure of adipose-derived MSCs to heat-inactivated Gram-negative bacteria and LPS induced osteogenic differentiation but reduced adipogenic differentiation. Heat-inactivated Gram-positive bacteria showed similar results, while LTA had no impact on the cells . In the current study, the loss in functional differentiation occurred with exposure to BCM of both strains, suggesting that the soluble products within the conditioned medias at the concentrations tested reduced the regeneration effects of MSCs. Although loss of cell viability may in part explain the reduced differentiation capacity of hBMSCs, use of multiple independent analysis requiring normalization of the data herein indicate a specific effect following treatment with BCM independent of cell loss.
Cellular migration and angiogenesis were assessed in the presence of BCM. Previous studies have observed increased cellular migration towards areas of S. aureus–infected cells  and increased cellular tube formation in the presence of bacteria , suggesting infectious pathogens promote migratory and angiogenic mechanisms of healing due to activation of the NF-κB pathway. Our results, however, indicate that migration, via a wound healing assay, and angiogenesis, via a tube formation assay, were significantly decreased with S. aureus and P. aeruginosa BCM present compared to growth controls. The explanation for this may possibly be due to the BCM pathogen-induced activation of specific toll-like receptors (TLRs). TLRs of MSCs have been identified as the recognition sites of bacterial structures, also known as pathogen-associated molecular patterns (PAMPs) [45,46]. For example, TLR4 is a receptor for LPS and TLR2 can bind bacterial lipoproteins. TLRs have been shown to affect proliferation and drive the critical stress responses of MSCs as well as disrupt normal differentiation pathways. In a recent study, MSCs that were treated with various TLR ligands showed induction of certain cytokines and chemokines, including TNF-α, chemokine ligand CCL2, CXCL10 interferon-gamma-inducible protein (IP10), IL-6, IL-8, interferon (IFN)1β, and NF-κB . Futhermore, TLR stimulation also triggered enhanced migration of MSCs . Activation of TLR3 in MSCs induced the release of trophic factors (IL-6, SDF-1, hepatocyte growth factor and VEGF), but inhibited proliferation and migration . Identifying these distinct recognition pathways have led to the theory that MSCs can be polarized by downstream TLR signaling to a series of specific phenotypes, including a pro-inflammatory pathway (TLR4 initiated), or an immunosuppressive pathway (TLR3 initiated) . The likely presence of multiple factors, representative of the planktonic and biofilm phenotypes, within the BCM suggests the possibility of TLR activation in MSCs, although the decrease in viability/proliferation with BCM may be adding a confounding factor that virtually eliminates healing functions. Future studies evaluating the role of TLRs in these processes are required to determine the exact mechanisms of action.
Despite functional assessments being hindered, trophic factors of hBMSCs in the presence of BCM were analyzed to determine if the innate healing cascade was activated during initial BCM exposure. MSC phenotype fate can be determined with minimal exposure to pathogens/agonists, with studies suggesting that as little as a one hour exposure can initiate changes, which has been used to mimic the gradient of danger signals that endogenous MSCs encounter and respond to at a distance from the injury site . The present study provided a continuous exposure to soluble biofilm products to more closely mimic the clinical setting of pathogens in a wound. Initial exposure was assessed for the early onset of cellular death or phenotypic change, based on release of inflammatory cytokines and upregulation of wound healing and antimicrobial cytokines. TNF-α and IL-6, both cytokines suggestive of a distressed, pro-inflammatory environment, were upregulated in the presence of BCM. TNF-α is a key regulator of the NF-κB pathway, which, as mentioned previously, regulates genes that influence migration, proliferation, differentiation and inflammation. Interestingly, TNF-α has been shown to stimulate MSC proliferation through the upregulation of cyclin D ; however, a severe decrease in proliferation and viability was observed after exposure to BCM even though TNF-α was significantly increased. IL-6 expression in cells, which typically exhibits immunomodulatory [45,50] and anti-inflammatory  responses, was similarly upregulated in hBMSCs in the presence of BCM. Previous reports demonstrate SDF-1 upregulation during inflammation processes in MSCs [11,12,52]. Our results illustrate that in the presence of soluble factors from biofilms, there was a significant increase in secreted SDF-1 protein. Secretion of VEGF, an important factor for mediation of angiogenesis, is increased in MSCs (specifically, adipose-derived stem cells) which were exposed to wound exudates . This process is part of a healing cascade during which MSCs exhibit angiogenic potential during inflammatory processes to contribute to oxygenation of a wound . The exposure of hBMSCs to BCM provided a similar result, with increased secreted VEGF. Human cathlicidin antimicrobial peptide hCAP-18/LL-37 has been identified as one of the factors that defines the antimicrobial activity of MSCs . The exposure of hBMSCs to BCM significantly increased the levels of secreted LL-37, suggesting that initial short-term presence of soluble factors from biofilms allowed for anticipated increases in antimicrobial activity. The assessment of these mediators indicates that the healing signals of hBMSCs followed the expected inflammatory responses according to the paracrine activity assessed.
Collectively this study demonstrates that in the presence of soluble factors released by biofilms, the regenerative capacity of MSCs is hindered or lost, while maintaining a secretory phenotype. The main findings of this study are that soluble factors released by mature biofilms of clinically relevant pathogens can induce initial inherent healing pathways; however, there is a negative impact on the viability of MSCs partially by induction of apoptosis, a hindrance of healing mechanisms of migration and angiogenesis, and incomplete multi-differentiation potential. The combination of these responses to biofilms gives insight to the non-healing aspect of chronic wounds, which typically have a strong biofilm presence; furthermore, these facts indicate that the use of cell-based therapies for the treatment of chronic wounds may have a less than desired effect for tissue regeneration in the context of infection. Future work may include the elucidation of the mechanisms of action of biofilms on MSCs to develop optimized therapies allowing MSCs to function in the presence of infection.
This work was supported by intramural funding from the Combat Casualty Care Research Program, Medical Research and Materiel Command to JCW. CLW and CJS are supported by a Post-doctoral Research Associate Fellowship through the National Academy of Sciences.
The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.
- Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen. 1996;4(3):321–5.PubMedView ArticleGoogle Scholar
- Fazli M, Bjarnsholt T, Kirketerp-Moller K, Jorgensen B, Andersen AS, Krogfelt KA, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol. 2009;47(12):4084–9.PubMed CentralPubMedView ArticleGoogle Scholar
- Gjodsbol K, Christensen JJ, Karlsmark T, Jorgensen B, Klein BM, Krogfelt KA. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J. 2006;3(3):225–31.PubMedView ArticleGoogle Scholar
- James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16(1):37–44.PubMedView ArticleGoogle Scholar
- Scali C, Kunimoto B. An update on chronic wounds and the role of biofilms. J Cutan Med Surg. 2013;17(6):371–6.PubMedGoogle Scholar
- Palmer MP, Altman DT, Altman GT, Sewecke JJ, Ehrlich GD, Hu FZ, et al. Can we trust intraoperative culture results in nonunions? J Orthop Trauma. 2014;28(7):384–90.PubMedView ArticleGoogle Scholar
- Percival SL, Cutting KF. Biofilms: possible strategies for suppression in chronic wounds. Nurs Stand. 2009;23(32):64. 66, 68 passim.PubMedView ArticleGoogle Scholar
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7.PubMedView ArticleGoogle Scholar
- Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell. 2011;9(1):11–5.PubMed CentralPubMedView ArticleGoogle Scholar
- Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med. 2007;53(2):121–7.PubMedView ArticleGoogle Scholar
- Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101–9.PubMedView ArticleGoogle Scholar
- Stoicov C, Li H, Liu JH, Houghton J. Mesenchymal Stem Cells Utilize CXCR4-SDF-1 Signaling for Acute, but Not Chronic, Trafficking to Gastric Mucosal Inflammation. Dig Dis Sci. 2013;58(9):2466–77.PubMed CentralPubMedView ArticleGoogle Scholar
- van den Broek LJ, Kroeze KL, Waaijman T, Breetveld M, Sampat-Sardjoepersad SC, Niessen FB, et al. Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts and keratinocytes to burn wound exudates: potential role of skin specific chemokine CCL27. Tissue Eng Part A. 2014;20(1-2):197–209.PubMed CentralPubMedView ArticleGoogle Scholar
- Coffelt SB, Marini FC, Watson K, Zwezdaryk KJ, Dembinski JL, LaMarca HL, et al. The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci U S A. 2009;106(10):3806–11.PubMed CentralPubMedView ArticleGoogle Scholar
- Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 2007;449(7162):564–9.PubMedView ArticleGoogle Scholar
- Nijnik A, Hancock RE. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol. 2009;16(1):41–7.PubMedView ArticleGoogle Scholar
- Tomchuck SL, Zwezdaryk KJ, Coffelt SB, Waterman RS, Danka ES, Scandurro AB. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells. 2008;26(1):99–107.PubMed CentralPubMedView ArticleGoogle Scholar
- Rahyussalim A, Kusnadi Y, Ismail H, Lubis A, Kurniawati T, Merlina M. Effect of Staphylococcus aureus and Staphylococcus epidermidis debris and supernatant on bone marrow stromal cells growth. Acta Med Indones. 2012;44(4):304–9.PubMedGoogle Scholar
- Ding J, Ghali O, Lencel P, Broux O, Chauveau C, Devedjian JC, et al. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci. 2009;84(15–16):499–504.PubMedView ArticleGoogle Scholar
- Navarro M, Pu F, Hunt JA. The significance of the host inflammatory response on the therapeutic efficacy of cell therapies utilising human adult stem cells. Exp Cell Res. 2012;318(4):361–70.PubMedView ArticleGoogle Scholar
- Fiedler T, Salamon A, Adam S, Herzmann N, Taubenheim J, Peters K. Impact of bacteria and bacterial components on osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Exp Cell Res. 2013;319(18):2883–92.PubMedView ArticleGoogle Scholar
- Beenken KE, Blevins JS, Smeltzer MS. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun. 2003;71(7):4206–11.PubMed CentralPubMedView ArticleGoogle Scholar
- Sanchez Jr CJ, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:47.PubMed CentralPubMedView ArticleGoogle Scholar
- Sanchez Jr CJ, Ward CL, Romano DR, Hurtgen BJ, Hardy SK, Woodbury RL, et al. Staphylococcus aureus biofilms decrease osteoblast viability, inhibits osteogenic differentiation, and increases bone resorption in vitro. BMC Musculoskelet Disord. 2013;14:187.PubMed CentralPubMedView ArticleGoogle Scholar
- Secor PR, James GA, Fleckman P, Olerud JE, McInnerney K, Stewart PS. Staphylococcus aureus Biofilm and Planktonic cultures differentially impact gene expression, mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol. 2011;11:143.PubMed CentralPubMedView ArticleGoogle Scholar
- Mo IF, Yip KH, Chan WK, Law HK, Lau YL, Chan GC. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol. 2008;9:52.PubMed CentralPubMedView ArticleGoogle Scholar
- Hentze H, Schwoebel F, Lund S, Keel M, Ertel W, Wendel A, et al. In vivo and in vitro evidence for extracellular caspase activity released from apoptotic cells. Biochem Biophys Res Commun. 2001;283(5):1111–7.PubMedView ArticleGoogle Scholar
- Belibasakis GN, Meier A, Guggenheim B, Bostanci N. The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants. Cytokine. 2011;55(1):98–103.PubMedView ArticleGoogle Scholar
- Annabi B, Lee YT, Turcotte S, Naud E, Desrosiers RR, Champagne M, et al. Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation. Stem Cells. 2003;21(3):337–47.PubMedView ArticleGoogle Scholar
- Kachgal S, Carrion B, Janson IA, Putnam AJ. Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. J Cell Physiol. 2012;227(11):3546–55.PubMed CentralPubMedView ArticleGoogle Scholar
- Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L, et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg. 2009;36(4):644–50.PubMedView ArticleGoogle Scholar
- Liao W, Xie J, Zhong J, Liu Y, Du L, Zhou B, et al. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation. 2009;87(3):350–9.PubMedView ArticleGoogle Scholar
- Estrada R, Li N, Sarojini H, An J, Lee MJ, Wang E. Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol. 2009;219(3):563–71.PubMed CentralPubMedView ArticleGoogle Scholar
- Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11(4):377–91.PubMedView ArticleGoogle Scholar
- Petrie Aronin CE, Tuan RS. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today. 2010;90(1):67–74.PubMedView ArticleGoogle Scholar
- Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One. 2010;5(4):e10088.PubMed CentralPubMedView ArticleGoogle Scholar
- Thomson CH. Biofilms: do they affect wound healing? Int Wound J. 2011;8(1):63–7.PubMedView ArticleGoogle Scholar
- Black CE, Costerton JW. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing. Surg Clin North Am. 2010;90(6):1147–60.PubMedView ArticleGoogle Scholar
- Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 2009;17(3):354–9.PubMedView ArticleGoogle Scholar
- Malic S, Hill KE, Playle R, Thomas DW, Williams DW. In vitro interaction of chronic wound bacteria in biofilms. J Wound Care. 2011;20(12):569. –570, 572, 574–567.PubMedView ArticleGoogle Scholar
- Kirker KR, James GA, Fleckman P, Olerud JE, Stewart PS. Differential effects of planktonic and biofilm MRSA on human fibroblasts. Wound Repair Regen. 2012;20(2):253–61.PubMed CentralPubMedView ArticleGoogle Scholar
- Secor PR, Jennings LK, James GA, Kirker KR, Pulcini ED, McInnerney K, et al. Phevalin (aureusimine B) production by Staphylococcus aureus biofilm and impacts on human keratinocyte gene expression. PLoS One. 2012;7(7):e40973.PubMed CentralPubMedView ArticleGoogle Scholar
- Li Y, Liu YH, Li ZJ, Liu MY, Li YG, Jin H, et al. Staphylococcus aureus infection of intestinal epithelial cells induces human umbilical cord-derived mesenchymal stem cell migration. Int Immunopharmacol. 2013;15(1):176–81.PubMedView ArticleGoogle Scholar
- Im E, Choi YJ, Kim CH, Fiocchi C, Pothoulakis C, Rhee SH. The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8. Am J Physiol Gastrointest Liver Physiol. 2009;297(5):G999–1008.PubMed CentralPubMedView ArticleGoogle Scholar
- Liotta F, Angeli R, Cosmi L, Fili L, Manuelli C, Frosali F, et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells. 2008;26(1):279–89.PubMedView ArticleGoogle Scholar
- Brandau S, Jakob M, Hemeda H, Bruderek K, Janeschik S, Bootz F, et al. Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J Leukoc Biol. 2010;88(5):1005–15.PubMedView ArticleGoogle Scholar
- Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, et al. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell Immunol. 2011;270(2):207–16.PubMedView ArticleGoogle Scholar
- Mastri M, Shah Z, McLaughlin T, Greene CJ, Baum L, Suzuki G, et al. Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. Am J Physiol Cell Physiol. 2012;303(10):C1021–33.PubMed CentralPubMedView ArticleGoogle Scholar
- Bocker W, Docheva D, Prall WC, Egea V, Pappou E, Rossmann O, et al. IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells. J Mol Med (Berl). 2008;86(10):1183–92.View ArticleGoogle Scholar
- Bouffi C, Bony C, Courties G, Jorgensen C, Noel D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One. 2010;5(12):e14247.PubMed CentralPubMedView ArticleGoogle Scholar
- van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis. 1997;176(2):439–44.PubMedView ArticleGoogle Scholar
- Luster AD. Chemokines–chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338(7):436–45.PubMedView ArticleGoogle Scholar
- Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008;294(3):C675–82.PubMedView ArticleGoogle Scholar
- Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells. 2010;28(12):2229–38.PubMed CentralPubMedView ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.